This article explores the potential benefits of point-of-care testing in the ED. Price and St. John provide a detailed description on how to approach four common aspects of point-of-care testing (POCT) in the ED, specifically, the challenges of adopting POCT, the impact of POCT on clinical decisions, the impact of...

This paper is an up-to-date account of research and current clinical practice guideline recommendations. Chris Higgins summarizes the recommendations of 2 new guidance documents on the use of natriuretic peptides in heart failure. The first document is a systematic review of published research (up to 2016) on the role ...

Dyspnea (alternative names: breathlessness and shortness of breath) is a common reason for individuals to seek medical help either in primary care or the hospital emergency room. The possible causes are legion, so that assessment of the patient complaining of breathlessness is a common and often difficult diagnostic...

Central laboratory or point-of-care testing of blood to determine natriuretic peptide (either BNP or N-terminal proBNP) concentration has a clinically established role in the differential diagnosis of patients presenting with breathlessness; normal levels exclude a diagnosis of heart failure, a common cause of...

This short review aims to put the diagnostic options provided by state-of-the-art POCT  technology into perspective with the clinical challenges faced by physicians treating patients presenting with acute dyspnea.  Natriuretic peptides, hemoglobin, D-dimers and venous blood gases play a key role in the early...

Circulating concentrations of the hormone brain natriuretic peptide (BNP) and its precursor molecule, NT-proBNP are increased in those with heart failure. This has allowed a now established role for serum BNP and NT-proBNP testing in the investigation of patients presenting with shortness of breath, a cardinal symptom ...

The management at the emergency department of patients presenting with symptoms of chest pain and/or acute dyspnea accounts for a substantial proportion of emergency care resources. In the work-up of these patients the blood measurements of cardiac troponins and brain natriuretic peptides are recommended by current...

Point-of-care testing (POCT) for key laboratory variables may help clinicians assess the level of acuteness and the level of care necessary in the management of deteriorating ward patients. We used a multibiomarker POCT panel including B-type natriuretic peptide (BNP), D-dimer, myoglobin (Myo), creatine kinase MB...

The use of natriuretic peptides like B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) has increased during the last decade and so has the medical evidence of their utility. This article highlights natriuretic peptide synthesis and release. Based on essential clinical trials the article gives medical...

Recently developed high-sensitivity cardiac troponin (cTn) assays can measure approximately 10 times lower concentrations with high precision (coefficient of variation, <10 % at the 99th percentile of the upper reference limit) than conventional assays, and can measure cTn concentrations in at least 50 % of a reference ...